Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001966716-25-000004

GENERAL COUNSEL & CORP SEC sold 10,000 shares at $25.07 ($250,650)

  • GENERAL COUNSEL & CORP SEC acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-10-03 Option exercise 10b5-1 +10,000 $9.15 $91,500 21,831 D
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-10-03 Sale 10b5-1 −10,000 $25.07 $250,650 11,831 D
Derivatives
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-10-03 Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 34,800 D
Open-market sales · 10,000 sh · avg $25.07 · $250,650
Loading xslF345X05/form4-10072025_081001.xml…